rs2302531

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016203.4(PRKAG2):​c.1052-42C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.12 in 1,577,214 control chromosomes in the GnomAD database, including 13,342 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1123 hom., cov: 33)
Exomes 𝑓: 0.12 ( 12219 hom. )

Consequence

PRKAG2
NM_016203.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.757

Publications

5 publications found
Variant links:
Genes affected
PRKAG2 (HGNC:9386): (protein kinase AMP-activated non-catalytic subunit gamma 2) AMP-activated protein kinase (AMPK) is a heterotrimeric protein composed of a catalytic alpha subunit, a noncatalytic beta subunit, and a noncatalytic regulatory gamma subunit. Various forms of each of these subunits exist, encoded by different genes. AMPK is an important energy-sensing enzyme that monitors cellular energy status and functions by inactivating key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This gene is a member of the AMPK gamma subunit family. Mutations in this gene have been associated with Wolff-Parkinson-White syndrome, familial hypertrophic cardiomyopathy, and glycogen storage disease of the heart. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jan 2015]
PRKAG2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • PRKAG2-related cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • lethal congenital glycogen storage disease of heart
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
  • Wolff-Parkinson-White syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 7-151570267-G-A is Benign according to our data. Variant chr7-151570267-G-A is described in ClinVar as Benign. ClinVar VariationId is 260694.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.258 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016203.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAG2
NM_016203.4
MANE Select
c.1052-42C>T
intron
N/ANP_057287.2
PRKAG2
NM_001407021.1
c.1052-42C>T
intron
N/ANP_001393950.1
PRKAG2
NM_001407022.1
c.1049-42C>T
intron
N/ANP_001393951.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAG2
ENST00000287878.9
TSL:1 MANE Select
c.1052-42C>T
intron
N/AENSP00000287878.3
PRKAG2
ENST00000392801.6
TSL:1
c.920-42C>T
intron
N/AENSP00000376549.2
PRKAG2
ENST00000418337.6
TSL:1
c.329-42C>T
intron
N/AENSP00000387386.2

Frequencies

GnomAD3 genomes
AF:
0.106
AC:
16061
AN:
152046
Hom.:
1119
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0308
Gnomad AMI
AF:
0.0669
Gnomad AMR
AF:
0.172
Gnomad ASJ
AF:
0.172
Gnomad EAS
AF:
0.270
Gnomad SAS
AF:
0.213
Gnomad FIN
AF:
0.106
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.113
Gnomad OTH
AF:
0.126
GnomAD2 exomes
AF:
0.148
AC:
36287
AN:
245054
AF XY:
0.149
show subpopulations
Gnomad AFR exome
AF:
0.0287
Gnomad AMR exome
AF:
0.236
Gnomad ASJ exome
AF:
0.181
Gnomad EAS exome
AF:
0.262
Gnomad FIN exome
AF:
0.101
Gnomad NFE exome
AF:
0.113
Gnomad OTH exome
AF:
0.138
GnomAD4 exome
AF:
0.122
AC:
173407
AN:
1425050
Hom.:
12219
Cov.:
29
AF XY:
0.125
AC XY:
88296
AN XY:
708664
show subpopulations
African (AFR)
AF:
0.0271
AC:
881
AN:
32548
American (AMR)
AF:
0.225
AC:
9658
AN:
43008
Ashkenazi Jewish (ASJ)
AF:
0.181
AC:
4552
AN:
25208
East Asian (EAS)
AF:
0.277
AC:
10816
AN:
39074
South Asian (SAS)
AF:
0.199
AC:
16813
AN:
84356
European-Finnish (FIN)
AF:
0.106
AC:
5465
AN:
51342
Middle Eastern (MID)
AF:
0.132
AC:
734
AN:
5564
European-Non Finnish (NFE)
AF:
0.108
AC:
117013
AN:
1085316
Other (OTH)
AF:
0.127
AC:
7475
AN:
58634
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
6687
13374
20060
26747
33434
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4376
8752
13128
17504
21880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.106
AC:
16063
AN:
152164
Hom.:
1123
Cov.:
33
AF XY:
0.109
AC XY:
8113
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.0307
AC:
1276
AN:
41546
American (AMR)
AF:
0.172
AC:
2629
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.172
AC:
596
AN:
3472
East Asian (EAS)
AF:
0.270
AC:
1395
AN:
5176
South Asian (SAS)
AF:
0.213
AC:
1028
AN:
4820
European-Finnish (FIN)
AF:
0.106
AC:
1120
AN:
10568
Middle Eastern (MID)
AF:
0.0986
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
0.113
AC:
7663
AN:
67982
Other (OTH)
AF:
0.126
AC:
266
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
734
1468
2203
2937
3671
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.120
Hom.:
281
Bravo
AF:
0.106
Asia WGS
AF:
0.252
AC:
878
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
12
DANN
Benign
0.64
PhyloP100
0.76
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2302531; hg19: chr7-151267353; COSMIC: COSV55221795; COSMIC: COSV55221795; API